Progesterone Cream vs Progesterone Pills: Which One Actually Protects Your Uterus?

Is this you?

Progesterone pills are for you if:you have a uterus and you take estrogen in any systemic form — patch, gel, spray, pill, or a systemic ring like Femring. “Systemic” means it travels through your whole body.

You generally don’t need either one if:you’ve had a hysterectomy. No uterus, no lining to protect. (A clinician may still use progesterone for another reason — for example, some women with a history of endometriosis after hysterectomy.)

You may not need either one if:you use only low-dose vaginal estrogen — a cream, tablet, or a low-dose ring like Estring — for dryness or painful sex. That’s local, not systemic.

Progesterone cream may be worth asking your clinician about if:you are not taking systemic estrogen at all. The evidence there is thin, but the uterine-lining argument doesn’t apply to you the same way. Jump to that section.

The three numbers this page is built on

Those three numbers come from two different studies, measuring two different things. We are not going to pretend they’re the same test. A head-to-head trial of pills versus cream has never been run.

But here’s what “inadequate endometrial opposition” means in plain English: the lining was still growing. One woman in three, after a year on cream.

That’s not a rounding error. That’s the whole reason this page exists.

Find your row

Find yourself in that table before you read another word. Everything below depends on which row you’re in.

🧭 The Progesterone Route Checker

Answer four questions. Get the FDA-approved options that fit your situation, the trade-off attached to each one, and the exact questions to ask your clinician. Print it and bring it with you.

Nothing you enter is saved or sent anywhere. The full decision tree is summarized in the Find your row table above and in the FAQ section below, so you can follow it without the tool.

The right online HRT provider isn’t the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference, your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can’t resolve those for you, use The HRT Index’s Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn’t the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

⚠️ If a clinician prescribed you progesterone cream, do not stop it because of this page. Bring this page to your next appointment and ask one question: “How is my uterine lining being monitored?” A good answer exists. Get it.

Progesterone cream vs progesterone pills: the short answer

Progesterone cream and progesterone pills are not two doses of the same treatment. Oral micronized progesterone is an FDA-approved prescription drug with randomized trial evidence that it prevents endometrial hyperplasia. Progesterone cream — sold over the counter or made by a compounding pharmacy — has no FDA approval for that purpose and no trial evidence that it reliably achieves it.

Here’s the reframe that matters.

You think you’re choosing between comfort and inconvenience.You’re actually choosing between protection and partial protection.

Nobody told you that, because nobody showed you the biopsies.

“But they’re both bioidentical”

Yes. Both are.

Micronized progesterone — “micronized” just means ground into very fine particles so your gut can absorb it — is chemically identical to the progesterone your ovaries used to make. So is the progesterone in most creams.

“Bioidentical” tells you nothing about which one to take.It’s a word about chemistry. Your uterus doesn’t care about chemistry. It cares about how much progesterone actually reaches it.

The word that separates these two products is not bioidentical.

It’s absorbed.

First, which of these is you?

This is the fork that decides everything. If you have a uterus and take systemic estrogen, progesterone isn’t a comfort add-on — it’s the thing standing between estrogen and your uterine lining. If you have no uterus, you generally need no progestogen. If you use only low-dose vaginal estrogen, a progestogen is generally not required.

Two words, defined once, then we’ll use them freely.

Endometrium.The lining of your uterus. It’s the tissue that used to build up and shed each month.

Endometrial hyperplasia.That lining growing too thick. It’s not cancer. But it can turn into cancer if it keeps going. It is the specific thing progesterone is there to prevent.

Systemic estrogengoes everywhere in your body. Patch, gel, spray, oral tablet, or a systemic ring such as Femring. It reaches your brain, your bones — and your endometrium.

Local vaginal estrogen stays mostly where you put it. Low-dose vaginal cream, tablet, or a low-dose ring such as Estring, for dryness, burning, or painful sex.

Those two rings sound alike and they are not the same drug. If you’re not certain which one you have, that is a five-second question for your pharmacist, and it changes the answer to this entire page.

The FDA said this out loud in 2026, and almost nobody noticed

In November 2025, the FDA asked drugmakers to strip several risk warnings out of the boxed warning on hormone therapy products. Heart disease. Breast cancer. Probable dementia. All removed.

Then, in the same request, the FDA said to remove the endometrial cancer language too — “except in the systemic estrogen-alone drugs.”

Read that again.

The FDA loosened almost everything. It kept the endometrial cancer warning exactly where it matters: on estrogen taken without a progestogen.

That is the entire argument of this page. Made by the regulator. In writing.

And here’s the good news, up front

Generic oral micronized progesterone is one of the cheapest prescriptions in this whole category. Roughly $12 to $18 for a 30-day supply with a discount card. GoodRx lists it as low as $14.10 against an average retail price of $60.75.

Over-the-counter cream? Fifteen to forty dollars a jar, and prescription drug plans don’t cover it.

The protective option and the cheap option are the same option.That almost never happens in medicine. It’s happening here.

Why estrogen needs a partner: what the FDA’s own trial found

In the randomized trial submitted to the FDA for approval, postmenopausal women with an intact uterus took conjugated estrogens alone, conjugated estrogens plus 200 mg oral micronized progesterone, or placebo, for up to 36 months. Endometrial hyperplasia occurred in 6% of the estrogen-plus-progesterone group, versus 64% of the estrogen-alone group, versus 3% on placebo.

We didn’t read that in a summary. We opened the label.

The full numbers, straight from the prescribing information

Source: PROMETRIUM (progesterone, USP) Capsules, Prescribing Information, Rev. 02/2026, FDA Reference ID 5744934, Tables 3–4. 358 women randomized. Up to 36 months.

Look at the complex hyperplasia row. Zero versus twenty-three percent.

Complex hyperplasia is the kind that worries pathologists. Atypical is the kind that worries oncologists. On progesterone, one woman out of 117 had atypical changes. On estrogen alone, fourteen out of 115 did.

That is what “endometrial protection” means. It isn’t a vibe. It’s a biopsy result.

The nuance in the label that nobody publishes

Here’s a detail we found by reading the actual indication instead of a blog post about it.

Prometrium’s FDA-approved indication is for preventing endometrial hyperplasia in women with a uterus who are receiving conjugated estrogens tablets. Not estradiol patches. Not gel. Conjugated estrogens tablets.

Millions of women take oral progesterone alongside an estradiol patch. That combination is guideline-supported and it is standard practice worldwide. It is also, by the strict letter of that specific label, off-label.

We’re telling you because we said we’d trace every claim to a primary source, and the source says what it says. It doesn’t change the recommendation. It’s the kind of thing your clinician already knows and your search results don’t.

The dose on the label

200 mg at bedtime, for 12 days out of each 28-day cycle, alongside daily conjugated estrogens.

A continuous 100 mg daily regimen is also widely used and guideline-supported — the British Menopause Society lists both. It is not the regimen in that FDA indication.

Both of those sentences are true. Which one is right for you is a conversation, not an article.

Does progesterone cream protect the uterus?

Not reliably. In a 48-week study of postmenopausal women applying 40 mg/day of transdermal progesterone cream with 1 mg/day transdermal estradiol, 32% showed inadequate endometrial opposition on biopsy — meaning the lining was still proliferating or had become hyperplastic. Average endometrial thickness rose from 3.3 mm to 5.3 mm by week 24.

That study is Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. BJOG 2005;112(10):1402–6. Fifty-four women recruited. Forty-one completed. Mean age 57.4.

The full picture, assembled from three sources

Nobody had put these rows in one table. So we did.

Last verified: July 2026

Sources: Prometrium PI Rev. 02/2026 (Ref ID 5744934), Tables 3–4 · Vashisht et al., BJOG 2005;112(10):1402–6 · Stute P, Neulen J, Wildt L, “The impact of micronized progesterone on the endometrium: a systematic review,” Climacteric 2016.

Three caveats we’re obligated to give you

We’re going to argue against our own table for a minute. If we don’t, you shouldn’t trust the rest of it.

One. These aren’t the same study. The oral trial used conjugated estrogens. The cream trial used a transdermal patch. Different women, different designs, different endpoints, different decades. There has never been a head-to-head randomized trial of oral progesterone versus progesterone cream for endometrial protection.Nobody has run it. That’s a real gap and we’re not going to paper over it.

Two. “No cancer found” is not what safety looks like. Endometrial cancer takes years to develop. The longest cream study ran 48 weeks with 41 women who finished. Of course no cancer turned up. That’s what an underpowered study looks like. It is not the same as evidence of safety, and if a page tells you otherwise, close the tab.

Three. Two of the five cream studies did show adequate opposition.Both came from the same lead author. One ran 28 days. We think that’s too little to build a uterus-protection plan on. Here’s the citation so you can decide for yourself: Wren BG, McFarland K, Edwards L, et al., Climacteric2000;3:155–60.

Why the cream falls short, in one sentence from a clinician

Speaking to Hone Health, Dr. Chvotzkin put the mechanism plainly: “The progesterone molecule is too large to get absorbed through the skin properly.”

That’s the theory. Now here’s the number.

The blood-level gap nobody has converted

The medical literature on progesterone cream reports blood levels in nmol/L. The FDA’s Prometrium label reports them in ng/mL. Because of that, these numbers have never been placed side by side. Converted into matched units, 40 mg/day of progesterone cream produced a median plasma level of about 0.79 ng/mL, while 200 mg of oral micronized progesterone produces a peak of about 38.1 ng/mL.

We did the conversion ourselves. Here’s the arithmetic, so you can check it.

Progesterone has a molecular weight of 314.47 g/mol.

That means 1 ng/mL = 3.18 nmol/L.

Sources: Prometrium PI Rev. 02/2026, Table 1 · Vashisht A, et al., Gynecological Endocrinology 2005;21(2):101–5. Conversion by molecular weight, shown above.

The authors of the cream study described the levels their patients reached with one word: sub-luteal.Below what a healthy woman’s own ovary makes in the second half of an ordinary menstrual cycle.

Now let us tell you what’s wrong with our own table

C_max and median plasma level are not the same measurement.A peak is not an average. We are not going to write “forty-eight times less progesterone in your blood,” because that would be sloppy, and sloppy is how health pages lose people.

What we will write: peak concentrations on oral progesterone sit one to two orders of magnitude above the median levels reported with 40 mg/day of cream.That’s the defensible version, and it’s still an enormous gap.

Also look at those standard deviations. 38.1, plus or minus 37.8. Oral progesterone is itself wildly variable between women. This is not a story about cream being uniquely unpredictable. Absorption is messy across the board.

And blood level is a proxy, not the point.The point is the biopsy table above. The blood levels explain the biopsies. They don’t replace them. That’s the whole case. Levels are low. Biopsies match the levels.

Is progesterone cream FDA-approved?

No. There are three different things people call “progesterone cream,” and none of them is FDA-approved for endometrial protection. Over-the-counter creams are unapproved drugs. Compounded creams are made by a pharmacy for one patient and are not reviewed by the FDA as finished products. FDA-approved vaginal progesterone products do exist — but they are approved for fertility treatment, not for menopausal endometrial protection.

Compounded means a pharmacy mixes it to order, for one person, from a prescription. The raw ingredients may come from FDA-registered suppliers. The finished medicine is not FDA-approved. Those are two different statements and the second is the one that matters.

The three-way split

What an OTC progesterone cream label actually says

We went to DailyMed — the National Library of Medicine’s official drug label database — and pulled the listing for a 7.5% USP progesterone cream.

It carries the FDA’s standard disclaimer: this drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

Then, on the same label, the manufacturer’s own warning:

“FOR EXTERNAL COSMETIC USE ONLY.”

Two lines above that warning, the product description offers temporary relief from menopausal symptoms such as hot flashes.

We’re not going to editorialize. The label does it for us.

What compounding is actually for

We’re going to be fair here, because a page that pretends compounding has no legitimate use is arguing, not informing.

The American College of Obstetricians and Gynecologists, in Clinical Consensus No. 6, states that compounded bioidentical menopausal hormone therapy should not be routinely prescribed when FDA-approved formulations exist. The Endocrine Society puts it this way: there is no evidence-based medical need for compounded hormone therapy when an approved preparation is available.

“Routinely” and “when available” are doing real work in both sentences.

There are narrow, legitimate reasons to compound. An allergy to an ingredient in an approved product. A dose that isn’t manufactured. Those are real. Hold on to that first one — it comes back later, and it’s the reason one of these providers is genuinely useful.

The Menopause Society says the rest plainly: custom-compounded hormones are not safer or more effective than approved bioidentical hormones, and when progesterone levels run too low, you are not protected against endometrial cancer.

Speaking to Reuters in June 2026, Dr. Gillian Goddard of NYU Grossman School of Medicine said compounded products “could contain too much or too little progesterone,” leading to health problems and, potentially, expensive ultrasounds and biopsies. She said she always cautions against them.

We’re going to come back to that too, and we’re going to disagree with her slightly — carefully, and with our reasons on the table.

One correction, because it’s circulating and it’s wrong: you may read that the FDA prohibits compounding transdermal products. It does not. FDA’s proposed rule on drugs that are difficult to compound (Docket FDA-2023-N-0061, March 2024) specifically considered and excluded transdermal and topical delivery systems. That list is not final. If someone cites it at you as settled law, they haven’t read it.

What the FDA’s February 2026 label change did — and didn’t — do

On February 12, 2026, the FDA approved labeling changes to six menopausal hormone therapy products, removing risk statements about cardiovascular disease, breast cancer, and probable dementia from the boxed warning. Prometrium was the only progestogen-alone product on that list. No progesterone cream appeared on it, and none could have.

We opened the FDA’s published list. Here are all six products, by category:

*(Notice Estring, sitting in the “topical vaginal estrogen” row. Even the FDA files it separately from systemic estrogen. That’s your Estring-versus-Femring distinction, confirmed.)*

Three things fall out of that list. We verified each one on July 9, 2026. See also: HRT label changes 2026.

One. Cream couldn’t be on that list. It has no label to update.

Prometrium is the brand-name reference product for oral micronized progesterone. FDA-approved generic versions exist too, and they carry their own labeling. What none of them share with progesterone cream is the thing that matters here:

A compounded cream has no FDA-approved label. An over-the-counter cream has no FDA-approved label. There is nothing for the agency to revise.

When the FDA revised its guidance on hormone therapy, it could not send a letter to progesterone cream. There was no address.

If you’ve ever wondered what “FDA-approved” actually buys you, that’s it. It buys you a document the government can update when the science moves.

Two. We downloaded the new Prometrium label. The boxed warning is gone entirely.

We pulled the PDF straight from the FDA’s document archive: Rev. 02/2026, Reference ID 5744934.

The document opens with Description. Then Clinical Pharmacology. Then Clinical Studies, Indications, Contraindications, Warnings.

There is no Boxed Warning section.Not a shortened one. Not a softened one. It isn’t there.

As of our verification date, several large drug-information websites still described Prometrium as carrying a boxed warning. If you checked one of them in July 2026, you read a warning the FDA had removed five months earlier.

We’re not naming and shaming. We’re telling you to check the label, and we’re linking to it, because we did.

Three. The warning they kept is the one this page is about.

FDA’s own November 2025 instruction was to remove the endometrial cancer language “except in the systemic estrogen-alone drugs.”

Every other fear got dialed back. That one stayed.

The honest case against progesterone pills

Oral micronized progesterone has three real drawbacks, and you deserve all three before you hear anything good about it. It makes many women drowsy and dizzy. Brand-name Prometrium contains peanut oil and is contraindicated in peanut allergy. And oral progesterone supply has been tight — which means your pharmacy may simply not have it.

Let’s take them one at a time. No softening.

It will probably make you groggy

In the FDA registration trial, 15% of women taking 200 mg with estrogen reported dizziness, compared to 9% on placebo. In a separate trial at 400 mg, 24% reported dizziness versus 4% on placebo.

The label instructs bedtime dosing. It warns about driving and operating machinery. Some women describe feeling drunk — slurred words, blurred vision.

This is in the FDA’s own prescribing information. It is not rare. It is not in your head.If you took your first capsule and couldn’t function the next morning, you weren’t imagining it, and you weren’t doing it wrong.

Brand-name Prometrium contains peanut oil

Prometrium’s inactive ingredients include peanut oil. It is contraindicated in anyone allergic to peanuts. Full stop.

Generic micronized progesterone capsules don’t all use the same inactive ingredients. Ask your pharmacist to read you the inactive ingredient list for each generic they can order.That’s a real, specific ask, and most people never make it.

Supply has been tight

Progesterone prescriptions have exploded. Among women 45 and older, progesterone-containing HRT prescriptions more than tripled between January 2021 and May 2026, reaching roughly 12 women per 1,000 — and rose more than 19% in the months after the FDA’s label change alone, according to Truveta, whose health-record database covers more than 130 million patients.

Supply didn’t keep pace. As of June 2026, ASHP — the pharmacists’ association — listed certain oral progesterone capsule products from Amneal and Hikma in its shortage database. The FDA does not list progesterone as being in shortage. An HHS spokesperson said one manufacturer is experiencing delays while others have product available. Amneal said it has seen increased demand and is expanding capacity at its New York facility.

So you may hand over a valid prescription and be told no. That’s real. It’s maddening. And it’s why a lot of you found this page today.

And here is the pivot. This is the part nobody has told you.

The grogginess isn’t a defect in the pill. It’s a fingerprint of the route.

When you swallow progesterone, it goes through your liver before it reaches the rest of you. That’s called first-pass metabolism. Your liver converts part of the dose into allopregnanolone— a normal human metabolite that acts on the same brain receptors as sleep medication.

That first pass through the liver is what makes you drowsy.

It is also the pass that produces the blood levels in the FDA’s trial — the trial with the 6% number.

Progesterone cream skips the liver. That’s the selling point in every ad you’ve ever seen. Less liver, less allopregnanolone, less grogginess — and, in the study that measured it, a median of about 0.79 ng/mL in the blood.

Now be careful with what that does and doesn’t prove. Feeling groggy is not a personal test that your uterus is protected.If the pill doesn’t make you sleepy, that doesn’t mean it isn’t working. What the drowsiness proves is something simpler, and it’s enough:

Gentleness is not a feature of the cream. It’s a readout of how little is getting through.

Which leaves you with an honest trade, stated plainly:

Progesterone cream will not leave you groggy the way the pill can. If avoiding that is your single highest priority, cream delivers exactly what it promises. But the same thing that spares you the drowsiness — skipping the liver — is why the cream studies measured a median of about 0.79 ng/mL, and why a third of the women in the 48-week trial still had a lining that hadn’t been opposed.That’s the trade. Make it knowingly, with a clinician, and with a plan for monitoring — or don’t make it.

If the grogginess is genuinely unbearable, here’s where to go

Do not stop your progesterone and swap in a cream on your own. Do this instead.

Every row on that table has a real answer. Not one of them is over-the-counter cream.

Read more: Prometrium and generic progesterone · Bijuva · Progesterone: forms and routes

If you have a peanut allergy, read this before anything else

If you have a peanut allergy, brand-name Prometrium is contraindicated, and one popular telehealth provider will tell you to solve that by switching to its compounded progesterone body cream. We do not agree, and we’ll show you why. If you have a uterus and take systemic estrogen, the better questions are whether a peanut-free generic capsule exists, whether a compounded oral capsule fits, or whether a different progestogen entirely is right for you.

This section exists because we went and read the fine print.

What we found

On Winona’s progesterone capsule page, the FAQ answers the question directly. It states that Winona’s progesterone capsules contain peanut oil, and that women with a peanut allergy can choose the Progesterone Body Cream instead, which does not.

Then, a few answers up, the same FAQ says Winona’s body cream is formulated in its compounding pharmacies “to protect the uterus as effectively as oral capsules.”

Winona’s ingredient list for its capsules is public and does include peanut oil. That part is accurate and useful — more transparent, frankly, than most providers.

The equivalence claim is the problem. We could find no published endometrial biopsy data supporting it. The published transdermal progesterone data runs the other way: 32% inadequate opposition at 48 weeks, three of five studies failing to show adequate opposition, two cases of complex hyperplasia. A compounded cream is not FDA-approved as a finished product, which means no regulator has reviewed its potency, its absorption, or its effect on the endometrium.

So if you have a uterus, take systemic estrogen, and have a peanut allergy, the single most likely path by which you end up on a route with no endometrial protection evidence is that you read that FAQ and believed it.

We’re saying this about the provider that pays us the most. Read that sentence again, and then decide how much to trust the rest of this page.

What to do instead

Step 1. Ask your pharmacist to read you the inactive ingredients of every generic micronized progesterone they can order.Generics don’t all use identical excipients. This is the cheapest possible answer and it costs one phone call. Start here.

Step 2. If no peanut-free FDA-approved capsule is available, ask about a compoundedoral capsule.

Here’s the distinction the whole internet is missing. It is not compounded versus FDA-approved. It is oral versus skin.

A compounded progesterone capsule still goes through your liver. It still gets the first pass. It still produces the metabolites and, in principle, the blood levels. A compounded progesterone cream skips all of it.

Allergy to an ingredient in an approved product is one of the narrow, named reasons ACOG and the Endocrine Society say compounding is appropriate. This is exactly that situation.

Step 3. Know exactly what you’re accepting.

Midi’s Custom Rx capsule is a compounded product. It is notFDA-approved, and it does not carry Prometrium’s trial data. Dr. Goddard’s warning to Reuters — that compounded products could contain too much or too little progesterone — applies to it.

We are recommending it anyway, for one specific reader: a woman with a peanut allergy who has already checked the generics and needs an oral route. For her, the choice isn’t “compounded or approved.” It’s “compounded oral capsule, or compounded skin cream, or nothing.” Of those three, the oral capsule is the only one that preserves the mechanism the evidence rests on.

If that reasoning doesn’t sit right with you, don’t take it from us. Take these three sentences to your clinician and let her decide. That’s what she’s for.

Step 4. Ask about the alternatives that sidestep the question entirely. Medroxyprogesterone acetate. Bijuva. A levonorgestrel IUD. All below.

What to do if your pharmacy is out of progesterone capsules

Oral progesterone supply has been intermittently tight since demand surged after the FDA’s 2026 labeling change. If your pharmacy is out, the first move is to ask for a different manufacturer — availability varies by labeler and by wholesaler. Switching to progesterone cream is not on the list of appropriate alternatives.

This is the section we’d want if it were us. Work it in order.

Step 1 — Ask for a different manufacturer

Most pharmacies stock one generic. Different wholesalers carry different labelers.

This resolves it more often than anything else on this list, and it costs one phone call. Start here. Not with a new drug. Not with a new provider. With a phone call.

Step 2 — Ask whether the regimen can change, not the drug

200 mg for 12 days per cycle, and 100 mg daily continuous, are both used for endometrial protection. A 100 mg prescription may be fillable when the 200 mg is not.

Step 3 — Try an independent or mail-order pharmacy

Different supply channels than the chains. Genuinely different inventory.

Step 4 — Ask your clinician about a different progestogen

These are the real alternatives. None of them is a cream.

We are leaving the norethindrone correction on the page instead of quietly deleting the row. If we get something wrong, you should be able to see that we fixed it.

Step 5 — Cream is not on this tree, and here’s why

You’ll read that compounding pharmacies are permitted to copy a commercially available drug when the FDA has declared it in shortage. That’s true as far as it goes. But the FDA has not declared progesterone in shortage— a point the FDA itself made to Reuters in June 2026 — so that particular door isn’t currently open for progesterone.

What is open is compounding for a personalized dose or an ingredient allergy. And that pathway leads to a compounded capsule, under a clinician’s direction. Not a cream.

A supply problem is a supply problem. Switching to cream would turn it into a safety problem.

The disagreement we noticed, and why it exists

ASHP lists certain oral progesterone capsule products in shortage. The FDA does not list progesterone in shortage at all.

Both are telling the truth. They’re counting different things. ASHP’s list is built from reports by pharmacists, prescribers, and patients. The FDA’s data comes from manufacturers.A manufacturer running at full capacity doesn’t see the woman standing at the counter being turned away.

So ask both your pharmacist and your clinician. Bring it up. It’s not a trick question — it’s a real gap in how the country measures shortages, and you’re allowed to name it.

What if you’re not taking estrogen at all?

If you are not taking systemic estrogen, the endometrial protection argument does not apply to you the same way — there is no unopposed estrogen to oppose. That does not make progesterone cream effective. The Menopause Society does not recommend compounded bioidentical hormone therapy for hot flashes, and using a progestogen without estrogen is off-label for symptom relief either way.

This section exists because most pages skip it, and skipping it turns a decision guide into a scare piece. So: honestly. Here is every route, and exactly what its evidence does and doesn’t cover.

Sources: The Menopause Society 2022 Hormone Therapy Position Statement · Stute et al., Climacteric 2016 · DailyMed OTC progesterone cream listing.

The thing we’re not going to pretend

Some women feel better on progesterone cream.

That may be real. It may be placebo — which is powerful, and not the same as fake. It may be the modest absorption you do get. We can’t tell you it does nothing for symptoms, and we’re not going to pretend we can.

Here is what we can tell you, and it’s the only claim on this page we’d stake the site on:

Progesterone cream does not reliably protect an estrogen-exposed endometrium. Nobody should be using it for that job.

The day this changes for you

The day you start systemic estrogen, this page’s answer applies to you.

If you’re on cream today and about to add an estradiol patch next month — that’s the conversation to have before the patch goes on. Not after. Not at your next annual.

What each option costs

Generic oral micronized progesterone runs roughly $12 to $18 for a 30-day supply with a discount card, against an average retail price near $61. Brand-name Prometrium costs substantially more. Over-the-counter progesterone creams typically cost $15 to $40 per jar and are not covered by prescription drug benefits.

We’re showing you our method, not just our numbers.

Where a price must be confirmed at checkout or with your specific pharmacy, we say so rather than guessing. Prices change. Insurance coverage depends on your plan.

The math is not subtle.

The route with the FDA approval, the randomized trial, and the 6% hyperplasia number is also the cheapest thing on this table. The compounded cream costs roughly twice what the FDA-approved capsule costs, and your insurance won’t touch it.

More on coverage: Does insurance cover HRT?

Where to get FDA-approved progesterone prescribed online

Any licensed clinician can prescribe FDA-approved oral micronized progesterone. What differs between telehealth providers is whether they take your insurance, whether the prescription goes to your own pharmacy or ships from theirs, and whether they also sell compounded formulations alongside FDA-approved ones.

We evaluate providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, access. That’s The HRT Index Verification Standard. It is not a score. We don’t invent numbers.

Last verified: July 2026. Confirm current pricing and state availability at intake.

About Winona, because we link to them and you deserve to know

Winona pays us more than anyone else on this list. They are fourth.

Here’s why, in their own words. Winona’s site states that its compounded estrogen and progesterone body creams “are not regulated or approved by the FDA.” It also states its progesterone capsules are FDA-approved. Both statements are theirs. Both are accurate. We checked.

Their capsule is a legitimate product and a reasonable cash-pay option. Use the capsule.

Their body cream is where we part company. Winona’s own FAQ says the cream is formulated to protect the uterus as effectively as its oral capsules, and it tells women with peanut allergies to switch to the cream. We could find no published endometrial biopsy data behind that claim, and the published transdermal progesterone data points the other way. We’ve laid out every number above. Compare them yourself.

We are not going to recommend a compounded progesterone cream on a page that spends five thousand words explaining why progesterone cream does not reliably protect the endometrium. Not for a bigger commission. Not for a better conversion rate.

If that costs us money, it costs us money. You can verify every sentence in this section in two clicks. That’s the only reason to trust anything else on this page.

What we actually verified, and how

We researched this page by reading primary sources directly instead of summarizing other articles. We opened the FDA’s February 12, 2026 list of updated hormone therapy labels, downloaded the revised Prometrium prescribing information, read the trial tables inside it, and converted the blood-level figures from the progesterone cream literature into the same units the FDA label uses.

What we could not verify

• Midi Health’s standard-care state count. Their pages and third-party reviews disagree. Their Custom Rx progesterone page says all states except Arizona; that is a product page, not the clinic’s licensure map. Confirm at booking.
• Current provider pricing beyond published rates. Confirm at intake. We will not guess and label a guess as a fact.
• Whether any specific generic micronized progesterone is peanut-free. Excipients vary by manufacturer and change. Ask your pharmacist to read the label to you.

What this page is not

Editorial research, independently verified. Not medically reviewed by a clinician. Not medical advice.

We did not test these medications. We did not invent a reviewer. We did not score anyone. And when we found we’d made a mistake — the norethindrone row — we fixed it in public rather than deleting it.

Nine questions to ask before you pay

Screenshot this. Take it with you. It’s free and it always will be.

1. I have a uterus and I take estrogen. Which progestogen are you prescribing, and is it FDA-approved for endometrial protection?
2. Is what you’re prescribing me FDA-approved, or compounded? (Ask this even at a telehealth provider that offers both.)
3. Am I on 200 mg cyclic or 100 mg continuous — and why that one for me?
4. The pill makes me too drowsy to function. What can we change: the timing, the dose, or the route?
5. I have a peanut allergy. Which generic uses a different oil, and if none does, what’s my next option that still goes through my liver?
6. My pharmacy is out. Can you write for a different manufacturer, or send it somewhere else?
7. If I can’t get micronized progesterone at all, which alternative would you choose for me — and what’s the trade-off?
8. What symptom means I should call you immediately? (Answer: any unexpected vaginal bleeding.)
9. When do we re-check this?

Frequently asked questions

Is progesterone cream as effective as pills?

Not for protecting the uterine lining. Oral micronized progesterone is FDA-approved for that purpose, with a randomized trial showing 6% endometrial hyperplasia over 36 months versus 64% on estrogen alone. Progesterone cream has no such approval and no comparable trial.

Does progesterone cream protect the uterus?

Not reliably. In a 48-week study, 32% of women using 40 mg/day transdermal progesterone cream with transdermal estradiol had inadequate endometrial opposition on biopsy. Average lining thickness rose from 3.3 mm to 5.3 mm by week 24.

Is over-the-counter progesterone cream FDA-approved?

No. At least one OTC progesterone cream listed on DailyMed carries the FDA’s standard unapproved-drug disclaimer, and its own label reads “for external cosmetic use only” — while the product description offers relief from menopausal symptoms.

Can I use progesterone cream with estrogen?

Not as your only progestogen, if you have a uterus. Systemic estrogen thickens the endometrium, and progesterone cream does not reliably oppose that. If a clinician has prescribed you cream with estrogen, ask specifically how your lining is being monitored.

Why does progesterone make me so sleepy?

Your liver converts part of an oral progesterone dose into allopregnanolone, a natural metabolite that acts on the same brain receptors as sleep medication. In the FDA trial, 15% of women on 200 mg reported dizziness versus 9% on placebo. That’s why the label says to take it at bedtime.

Does feeling groggy mean the progesterone is working?

No. Drowsiness is a side effect of the oral route, not a test of whether your uterine lining is protected. Some women take oral progesterone with no sedation at all and are fully protected. Only your clinician, and if needed an ultrasound or biopsy, can assess your lining.

Does Prometrium still have a black box warning?

The updated Prometrium prescribing information, Rev. 02/2026, does not contain a boxed warning section. As of July 2026, several major drug-information websites had not updated. We link to the FDA’s PDF. Read it yourself — it takes ninety seconds.

What can I take instead of progesterone pills?

FDA-approved options include medroxyprogesterone acetate and the combination product Bijuva. Vaginal progesterone and the levonorgestrel IUD are used off-label for this purpose. Standalone norethindrone acetate is not approved for use with estrogen for endometrial protection. Progesterone cream is not an appropriate substitute.

I have a peanut allergy. Should I switch to progesterone cream?

Not as your only progestogen if you have a uterus and take systemic estrogen. Ask your pharmacist whether any FDA-approved generic micronized progesterone is peanut-free. If none is, a compounded oral capsule keeps the liver metabolism that the evidence depends on. A skin cream does not.

Is progesterone cream safe long-term?

Unknown. The longest study of transdermal progesterone cream with estrogen ran 48 weeks with 41 women completing. Endometrial cancer develops over years. No study has run long enough or enrolled enough women to answer this question.

Do I need progesterone if I’ve had a hysterectomy?

Generally no. Progesterone’s role in menopausal hormone therapy is protecting the uterine lining, and without a uterus there is no lining to protect. Some exceptions exist — a history of endometriosis, for example — so confirm with your clinician.

Do I need progesterone with vaginal estrogen?

Generally no, if you use low-dose vaginal estrogen only — a cream, tablet, or a low-dose ring like Estring. It acts locally rather than throughout your body. A systemic ring such as Femring is different. Confirm which one you have. → Vaginal estrogens

Is compounded progesterone cream different from over-the-counter cream?

Different in origin, identical in FDA status. Compounded cream is prescribed and made by a pharmacy for one patient. OTC cream is bought off a shelf. Neither finished product is FDA-approved, and neither is approved for endometrial protection.

Is progesterone cream cheaper than pills?

Usually not. Generic micronized progesterone capsules run about $12 to $18 per month with a discount card and are typically covered on Tier 1 or 2 of insurance formularies. One telehealth provider lists its compounded progesterone body cream from $89 a month — more than twice its own FDA-approved capsule.

What’s the difference between progesterone and progestin?

Progesterone is the hormone your body makes. Progestins are synthetic versions built to act like it. Both are progestogens, and both can protect the endometrium. Their risk profiles differ — medroxyprogesterone acetate, a progestin, was the one used in the Women’s Health Initiative arm that showed increased breast cancer risk.

Is “bioidentical” the same as FDA-approved?

No. “Bioidentical” describes chemical structure. Many FDA-approved products are bioidentical, including oral micronized progesterone and estradiol patches. Many compounded products are also bioidentical and are not FDA-approved. The word tells you nothing about whether the medicine reaches your uterus.

Where this leaves you

If you have a uterus and you take systemic estrogen: take the pill.

Take it at bedtime. The grogginess isn’t a defect. It’s the fingerprint of the route that has the trial data behind it.

If your pharmacy is out, ask for a different manufacturer before you ask for anything else.

If you have a peanut allergy, ask your pharmacist about the generics before anyone sells you a cream.

And if a clinician has you on cream, don’t stop. Just ask the one question on this page that matters most: how is my uterine lining being monitored?

You came here wondering whether you could take the easier road without giving anything up.

Now you know exactly what you’d be giving up. That isn’t a scolding. It’s permission— to stop second-guessing the capsule on your nightstand, to stop reading the drowsiness as a warning sign, and to walk into your next appointment knowing more than you did an hour ago.

That’s not a small thing. Most women never get it.

Sources

FDA and regulatory

• FDA. PROMETRIUM (progesterone, USP) Capsules — Prescribing Information, Rev. 02/2026, Reference ID 5744934.
• FDA. Menopausal Hormone Therapies with Updated Prescribing Information, content current 02/12/2026.
• FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, February 12, 2026.
• FDA. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies, November 10, 2025.
• FDA. Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding (proposed rule), 89 FR 19776, Docket FDA-2023-N-0061, March 20, 2024.
• FDA. Compounding When Drugs Are on FDA’s Drug Shortages List.
• DailyMed. NORETHINDRONE ACETATE tablet label.
• DailyMed. MEDROXYPROGESTERONE ACETATE tablet label.
• DailyMed. Listing for a 7.5% USP progesterone cream carrying the FDA unapproved-drug disclaimer.
• FDA. BIJUVA (estradiol and progesterone) capsules, Prescribing Information.

Clinical literature

• Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime. BJOG 2005;112(10):1402–6.
• Vashisht A, et al. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen. Gynecological Endocrinology 2005;21(2):101–5.
• Stute P, Neulen J, Wildt L. The impact of micronized progesterone on the endometrium: a systematic review. Climacteric 2016.
• Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000;3:155–60.

Guidelines

• The Menopause Society. 2022 Hormone Therapy Position Statement; patient education on hormone therapy.
• American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy, Clinical Consensus No. 6.
• Endocrine Society. Compounded Bioidentical Hormone Therapy position statement.
• British Menopause Society. Progestogens and Endometrial Protection (Tool for Clinicians), May 2026.

Supply, pricing, and reporting (re-verify before relying on these)

• Reuters. “US progesterone supplies tighten as menopause treatment demand grows,” June 17, 2026. Includes Truveta prescription data, the FDA’s shortage position, Amneal’s statement, and Dr. Gillian Goddard’s remarks.
• ASHP Drug Shortage Bulletin, Progesterone Capsules.
• FDA Drug Shortage Database.
• GoodRx, progesterone (coupon prices last updated 06/22/26).
• Drugs.com price guide, progesterone.

Provider statements (each provider’s own site)

• bywinona.com/hormone-replacement-therapy · bywinona.com/product/progesterone-capsule
• joinmidi.com/hrt · joinmidi.com/store/progesterone · joinmidi.com/pricing-insurance
• forhers.com/perimenopause
• sesamecare.com/service/menopause-treatment
• Hone Health, “Oral Progesterone Alternatives,” quoting Dr. Chvotzkin.

Last verified: July 2026 · Next scheduled re-verification: October 2026